Virtu Financial’s Minerva Neurosciences NERV Stock Holding History

Virtu Financial’s Portfolio NERV Stock Details NERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,993	Closed	-$192K	–	1675
2023 Q2	$192K	Buy	+20,993	New	+$111K	0.01%	830
2022 Q1	–	Sell	-3,762	Closed	-$24K	–	1839
2021 Q4	$24K	Sell	3,762 -3,469	-48%	-$32.7K	﹤0.01%	1496
2021 Q3	$101K	Buy	7,231 +5,307	+276%	+$79.8K	0.01%	1150
2021 Q2	$36K	Buy	+1,924	New	+$41.4K	﹤0.01%	1374
2021 Q1	–	Sell	-7,570	Closed	-$142K	–	1881
2020 Q4	$142K	Buy	+7,570	New	+$191K	0.02%	964
2020 Q3	–	Sell	-1,344	Closed	-$39K	–	1348
2020 Q2	$39K	Buy	+1,344	New	+$78.8K	﹤0.01%	1040
2017 Q4	–	Sell	-1,902	Closed	-$116K	–	2784
2017 Q3	$116K	Buy	+1,902	New	+$109K	0.01%	2034

Other funds holding NERV

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's NERV Position: Q3 2023 in Review

Virtu Financial sold out of Minerva Neurosciences (NERV) in Q3 2023, closing a stake of 20,993 shares — an estimated $192K sold.

Virtu Financial first reported a position in NERV in Q3 2017 and held it in 7 quarters. The position peaked at $192K in Q2 2023. 20 funds tracked by Wall St. Rank hold NERV as of Q3 2023.

Virtu Financial reported no remaining Minerva Neurosciences position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 20,993 Minerva Neurosciences shares in Q3 2023, an estimated $192K.
Virtu Financial first reported a position in Minerva Neurosciences in Q3 2017 and held it in 7 quarters.
Virtu Financial's Minerva Neurosciences position peaked at $192K in Q2 2023.
20 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.